Despite the use of interruption devices for over three decades, the role of inferior vena cava interruption in the management of thromboembolic disease remains controversial. It is the purpose of this article to set guidelines for interrupting the inferior vena cava in patients with thromboembolic disease and to review the two methods of interruption-the direct and the transvenous approach.
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Critical Care and Intensive Care Medicine
- Cardiology and Cardiovascular Medicine